Meeting
2016 ASCO Annual Meeting
Sensor-controlled scalp cooling to prevent chemotherapy-induced alopecia in women treated for either breast or female genital tract cancer: A German experience using the Paxman system.
Authors
Christian M. Kurbacher
Gynecologic Center Bonn-Friedensplatz, Bonn, Germany
Christian M. Kurbacher , Susanne Herz , Gabriele Kolberg , Nele Kettelhoit , Claudia Schweitzer , Katja Monreal , Jutta Anna Kurbacher
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Palliative Care and Symptom Management
Citation
J Clin Oncol 34, 2016 (suppl; abstr 10118)
DOI
10.1200/JCO.2016.34.15_suppl.10118
Abstract #
10118
Poster Bd #
106
Abstract Disclosures
Similar Posters
Poster
2017 ASCO Annual Meeting
Scalp Cooling Alopecia Prevention trial (SCALP) for patients with early stage breast cancer.
First Author: Julie R. Nangia
Poster
2011 ASCO Annual Meeting
Clinical performance, efficacy, and safety of the DigniCap system, a scalp-hypothermia system, in preventing chemotherapy (CTX)-induced alopecia in patients (pts) with early-stage breast cancer (BC).
First Author: A. Glencer
Poster
2022 ASCO Quality Care Symposium
Investigating keratinocyte growth factor hair serum for the prevention of chemotherapy-induced alopecia.
First Author: Preethika Potluri
Poster
2022 ASCO Annual Meeting
Hair Safe Study: Effects of scalp cooling on hair preservation and hair regrowth in breast cancer therapy—A prospective interventional study.
First Author: Christine Brunner